Lupin to acquire Dutch ophthalmology firm VISUfarma
The logo of Lupin is seen on the facade of its pharmaceutical plant in Goa. | Photo Credit: Reuters Drugmaker Lupin will acquire Dutch firm VISUfarma in a transaction that pegs the enterprise value of the Amsterdam-based specialty pharmaceutical company focused on ophthalmology at euro 190 million. A portfolio company of global healthcare specialist investor […]
Continue Reading
